Article info
PDFClinical and epidemiological research
Extended report
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
- Correspondence to Professor Dirk Foell, Institute of Immunology, University of Muenster, Roentgenstr. 21, D-48149 Muenster, Germany; dfoell{at}uni-muenster.de
Citation
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
Publication history
- Received January 13, 2012
- Accepted April 19, 2012
- First published June 11, 2012.
Online issue publication
February 17, 2018
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions